vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与System1, Inc.（SST）财务数据对比。点击上方公司名可切换其他公司
PUMA BIOTECHNOLOGY, INC.的季度营收约是System1, Inc.的1.5倍（$75.5M vs $51.9M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -31.3%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -21.8%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
System1是一家美国互联网广告企业，成立于2013年，前身为OpenMail，总部位于加利福尼亚州玛丽娜德尔雷。该公司主打获客响应营销平台业务，将隐私保护作为核心经营重点之一，但也曾因对Startpage.com等主打隐私的平台的影响受到批评。
PBYI vs SST — 直观对比
营收规模更大
PBYI
是对方的1.5倍
$51.9M
营收增速更快
PBYI
高出59.0%
-31.3%
两年增速更快
PBYI
近两年复合增速
-21.8%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $51.9M |
| 净利润 | — | $-13.5M |
| 毛利率 | 69.3% | 41.0% |
| 营业利润率 | 22.7% | -33.6% |
| 净利率 | — | -26.0% |
| 营收同比 | 27.7% | -31.3% |
| 净利润同比 | — | 4.8% |
| 每股收益（稀释后） | $0.26 | $-3.58 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYISST
| Q4 25 | $75.5M | $51.9M | ||
| Q3 25 | $54.5M | $61.6M | ||
| Q2 25 | $52.4M | $78.1M | ||
| Q1 25 | $46.0M | $74.5M | ||
| Q4 24 | $59.1M | $75.6M | ||
| Q3 24 | $80.5M | $88.8M | ||
| Q2 24 | $47.1M | $94.6M | ||
| Q1 24 | $43.8M | $84.9M |
净利润PBYISST
| Q4 25 | — | $-13.5M | ||
| Q3 25 | $8.8M | $-18.5M | ||
| Q2 25 | $5.9M | $-17.5M | ||
| Q1 25 | $3.0M | $-15.9M | ||
| Q4 24 | — | $-14.2M | ||
| Q3 24 | $20.3M | $-23.6M | ||
| Q2 24 | $-4.5M | $-26.4M | ||
| Q1 24 | $-4.8M | $-10.5M |
毛利率PBYISST
| Q4 25 | 69.3% | 41.0% | ||
| Q3 25 | 77.7% | 36.9% | ||
| Q2 25 | 76.5% | 35.7% | ||
| Q1 25 | 77.1% | 38.2% | ||
| Q4 24 | 76.4% | 42.1% | ||
| Q3 24 | 63.9% | 28.0% | ||
| Q2 24 | 77.4% | 27.6% | ||
| Q1 24 | 75.5% | 21.9% |
营业利润率PBYISST
| Q4 25 | 22.7% | -33.6% | ||
| Q3 25 | 17.6% | -25.3% | ||
| Q2 25 | 12.7% | -20.4% | ||
| Q1 25 | 8.7% | -17.6% | ||
| Q4 24 | 22.6% | -15.7% | ||
| Q3 24 | 27.4% | -24.6% | ||
| Q2 24 | -4.6% | -30.8% | ||
| Q1 24 | -5.3% | -30.4% |
净利率PBYISST
| Q4 25 | — | -26.0% | ||
| Q3 25 | 16.2% | -30.1% | ||
| Q2 25 | 11.2% | -22.4% | ||
| Q1 25 | 6.5% | -21.3% | ||
| Q4 24 | — | -18.7% | ||
| Q3 24 | 25.2% | -26.6% | ||
| Q2 24 | -9.6% | -27.9% | ||
| Q1 24 | -11.0% | -12.4% |
每股收益（稀释后）PBYISST
| Q4 25 | $0.26 | $-3.58 | ||
| Q3 25 | $0.17 | $-2.30 | ||
| Q2 25 | $0.12 | $-2.23 | ||
| Q1 25 | $0.06 | $-0.21 | ||
| Q4 24 | $0.40 | $-3.41 | ||
| Q3 24 | $0.41 | $-3.37 | ||
| Q2 24 | $-0.09 | $-3.80 | ||
| Q1 24 | $-0.10 | $-0.16 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $86.9M |
| 总债务越低越好 | $22.7M | $305.1M |
| 股东权益账面价值 | $130.3M | $30.5M |
| 总资产 | $216.3M | $405.0M |
| 负债/权益比越低杠杆越低 | 0.17× | 10.01× |
8季度趋势，按日历期对齐
现金及短期投资PBYISST
| Q4 25 | $97.5M | $86.9M | ||
| Q3 25 | $94.4M | $54.6M | ||
| Q2 25 | $96.0M | $63.6M | ||
| Q1 25 | $93.2M | $43.9M | ||
| Q4 24 | $101.0M | $63.6M | ||
| Q3 24 | $96.7M | $69.1M | ||
| Q2 24 | $96.8M | $75.7M | ||
| Q1 24 | $107.2M | $69.9M |
总债务PBYISST
| Q4 25 | $22.7M | $305.1M | ||
| Q3 25 | $34.0M | $259.2M | ||
| Q2 25 | $45.3M | $263.3M | ||
| Q1 25 | $56.7M | $267.4M | ||
| Q4 24 | $68.0M | $255.1M | ||
| Q3 24 | $79.3M | $259.2M | ||
| Q2 24 | $90.7M | $263.3M | ||
| Q1 24 | $102.0M | $268.6M |
股东权益PBYISST
| Q4 25 | $130.3M | $30.5M | ||
| Q3 25 | $115.3M | $42.7M | ||
| Q2 25 | $104.7M | $58.2M | ||
| Q1 25 | $97.1M | $67.2M | ||
| Q4 24 | $92.1M | $80.3M | ||
| Q3 24 | $71.1M | $90.3M | ||
| Q2 24 | $48.5M | $109.4M | ||
| Q1 24 | $51.0M | $131.7M |
总资产PBYISST
| Q4 25 | $216.3M | $405.0M | ||
| Q3 25 | $202.9M | $385.2M | ||
| Q2 25 | $194.9M | $429.2M | ||
| Q1 25 | $196.2M | $419.2M | ||
| Q4 24 | $213.3M | $459.1M | ||
| Q3 24 | $220.7M | $479.3M | ||
| Q2 24 | $205.0M | $511.3M | ||
| Q1 24 | $214.1M | $521.1M |
负债/权益比PBYISST
| Q4 25 | 0.17× | 10.01× | ||
| Q3 25 | 0.30× | 6.07× | ||
| Q2 25 | 0.43× | 4.53× | ||
| Q1 25 | 0.58× | 3.98× | ||
| Q4 24 | 0.74× | 3.18× | ||
| Q3 24 | 1.12× | 2.87× | ||
| Q2 24 | 1.87× | 2.41× | ||
| Q1 24 | 2.00× | 2.04× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $-10.6M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | — |
| 自由现金流率自由现金流/营收 | 19.1% | — |
| 资本支出强度资本支出/营收 | 0.0% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $41.7M | — |
8季度趋势，按日历期对齐
经营现金流PBYISST
| Q4 25 | $14.4M | $-10.6M | ||
| Q3 25 | $9.7M | $-2.1M | ||
| Q2 25 | $14.1M | $24.5M | ||
| Q1 25 | $3.6M | $-15.9M | ||
| Q4 24 | $15.6M | $772.0K | ||
| Q3 24 | $11.0M | $-5.0K | ||
| Q2 24 | $1.0M | $10.0M | ||
| Q1 24 | $11.2M | $-16.0M |
自由现金流PBYISST
| Q4 25 | $14.4M | — | ||
| Q3 25 | $9.7M | — | ||
| Q2 25 | $14.1M | — | ||
| Q1 25 | $3.6M | $-16.0M | ||
| Q4 24 | $15.6M | — | ||
| Q3 24 | $11.0M | $-36.0K | ||
| Q2 24 | $1.0M | — | ||
| Q1 24 | — | — |
自由现金流率PBYISST
| Q4 25 | 19.1% | — | ||
| Q3 25 | 17.7% | — | ||
| Q2 25 | 26.8% | — | ||
| Q1 25 | 7.7% | -21.5% | ||
| Q4 24 | 26.4% | — | ||
| Q3 24 | 13.7% | -0.0% | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | — | — |
资本支出强度PBYISST
| Q4 25 | 0.0% | 0.0% | ||
| Q3 25 | 0.0% | 0.0% | ||
| Q2 25 | 0.0% | 0.0% | ||
| Q1 25 | 0.1% | 0.1% | ||
| Q4 24 | 0.0% | 0.0% | ||
| Q3 24 | 0.0% | 0.0% | ||
| Q2 24 | 0.0% | 0.0% | ||
| Q1 24 | 0.0% | 0.0% |
现金转化率PBYISST
| Q4 25 | — | — | ||
| Q3 25 | 1.10× | — | ||
| Q2 25 | 2.41× | — | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
